Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
    • Research
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Treatment
  4. /
  5. Minnelide

Minnelide

April 12, 2017
Minnelide
Trade Name Minnelide (Tm)
Orphan Indication Pancreatic Cancer
USA Market Approval USA
USA Designation Date 2013-02-18 00:00:00
Sponsor Minneamrita Therapeutics, LLC;6 Hickory Court;Rock Island, Illinois, 61201
Related Access Program
Baxalta – Pancreatic Cancer University of Roma La Sapienza – Pancreatic Cancer University of Roma La Sapienza – Pancreatic Cancer

Related Treatment

  • Istiratumab
  • Eflornithine + sulindac
  • 4-amino-1-[(1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)cyclopen
  • Ubidecarenone
  • Upamostat
More Treatment
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2025 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo